Amgen Waged Lawfare To Overcharge For Drug, Suit Claims
By Corey Rothauser · August 7, 2024, 7:48 PM EDT
Maryland-based independent licensees of the Blue Cross Blue Shield Association claim pharmaceutical giant Amgen Inc. and its subsidiaries have engaged in unlawful monopolistic practices that have inflated the cost of the...
To view the full article, register now.